These CD8+ T cells auto-aggressively eliminate cells in an MHC-I-independent manner, which is associated with HCC progression in NASH patients driven by chronic liver injury [55]. The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatohepatitis.